Bovine Kobuvirus: Veterinary Reference

Overview and Taxonomy of Bovine Kobuvirus: Veterinary Reference

Taxonomic Position and Phylogenetic Framework

Bovine kobuvirus (BKV) is a member of the genus Kobuvirus within the family Picornaviridae, a large and diverse family of non-enveloped, single-stranded, positive-sense RNA viruses. The genus Kobuvirus was originally established with two officially recognized species: Aichivirus A (formerly Aichi virus, first identified in humans in 1989) and Aichivirus B (formerly Bovine kobuvirus, first characterized in cattle in Japan in 2003) [6, 7]. A third candidate species, Aichivirus C (porcine kobuvirus), was subsequently proposed following detection in swine in Hungary and China [6, 7]. The taxonomic delineation within the genus is based on genetic divergence thresholds, particularly within the coding region, where nucleotide identities between species range from approximately 35% in the leader (L) protein to 74% in the 3D RNA-dependent RNA polymerase region [6]. Bovine kobuvirus, therefore, occupies a distinct phylogenetic lineage that is more closely related to porcine kobuvirus than to Aichi virus, yet forms a separate clade within the ruminant kobuvirus cluster [1, 6].

The genome of BKV is approximately 8.2–8.4 kb in length and exhibits the canonical picornavirus organization: a single open reading frame (ORF) encoding a polyprotein of roughly 2,480 amino acids, flanked by 5′ and 3′ untranslated regions (UTRs) [1, 2]. The polyprotein is cleaved into structural proteins (VP0, VP3, and VP1) and nonstructural proteins (2A–2C and 3A–3D), with the L protein situated at the N-terminus preceding the capsid region [2, 6]. This genomic architecture is conserved across kobuviruses, though sequence variability in specific regions, particularly the L protein and VP1, underpins the genetic diversity observed among BKV strains globally [2].

Genetic Architecture and Genotypic Diversity

Whole-genome sequencing of BKV isolates from diverse geographic regions has revealed substantial genetic heterogeneity, enabling the classification of circulating strains into distinct genotypes. A landmark study from Yunnan Province, China, reported the complete genome sequences of two BKV strains (YN-1 2023 and YN-2 2023), which were 8,289 bp and 8,291 bp in length, respectively [2]. Phylogenetic analysis placed both strains within genotype B, the dominant genotype circulating in China, and demonstrated close genetic affinity to the previously characterized Chinese strain BKV 13/2021 [2]. Genome-wide nucleotide identities among BKV isolates ranged from 39.9% to 93.9%, with the highest similarity observed between the Yunnan strains and BKV 13/2021 CHN [2]. Notably, the ORF exhibited nucleotide and amino acid similarities of 48.7–93.9% and 29.3–98.5%, respectively, underscoring the extensive genetic plasticity of this virus [2].

Comparative analysis of the Yunnan isolates revealed that the structural proteins VP0 and VP3, along with the nonstructural proteins, were highly conserved (97.8–100% amino acid identity) relative to BKV 13/2021 CHN, whereas the L protein displayed the lowest similarity (94.7–95.2%) [2]. This pattern of conservation suggests that the L protein may be under differential selective pressure, potentially related to host adaptation or immune evasion. Furthermore, the 5′ UTR showed lower conservation than the 3′ UTR, indicating possible regulatory variations that could influence translation efficiency or viral replication dynamics [2]. These findings align with earlier work demonstrating that the 3D and VP1 genes are useful targets for molecular epidemiology, as they harbor sufficient nucleotide substitutions to discriminate between strains while retaining regions of high conservation for primer design [1].

Host Range and Cross-Species Transmission

Although BKV was initially identified in cattle, subsequent surveillance has expanded its known host range to include other ruminant species. In a study from Minnesota, USA, a novel caprine kobuvirus (strain MN604700) was detected in diarrheic goat kids, with the complete genome (8,139 nt) sharing 93% nucleotide identity with the caprine kobuvirus reference strain [1]. Phylogenetic analysis revealed that this caprine clade was more closely related to porcine kobuviruses than to bovine or ovine kobuviruses, suggesting a complex evolutionary history involving cross-species transmission events [1]. Similarly, in Hungary, ovine kobuvirus was detected in fecal samples from healthy lambs, with the partial 3D/3′ UTR region exhibiting 89% nucleotide and 97% amino acid identity to bovine kobuvirus [6]. The high prevalence (62.5%) in young sheep and the phylogenetic sublineage position of the ovine strain relative to bovine strains raised the possibility that kobuvirus may circulate naturally in multiple ruminant hosts, or alternatively, that sheep may serve as passive reservoirs through fecal-oral transmission from nearby cattle [6].

The detection of BKV in goats, sheep, and cattle across disparate geographic regions, including North America, Europe, Asia, and South America, indicates that kobuviruses are globally distributed and capable of infecting a broad range of livestock species [1-3, 6]. In Colombia, viral metagenomic analysis of fecal samples from cattle in Ubaté Province revealed BKV in 52% of samples, marking the first report of this virus in the country [3]. The consistent detection of BKV in both diarrheic and apparently healthy animals suggests that infection may be endemic in many cattle populations, with subclinical shedding contributing to environmental contamination and transmission [1, 3].

Epidemiological Context and Clinical Significance

BKV is considered an emerging pathogen associated with enteric disease in cattle, particularly neonatal diarrhea, which represents a major cause of morbidity, mortality, and economic loss in the livestock industry worldwide [2]. The prevalence of BKV in diarrheic calves varies considerably by region; for example, a study in Yunnan Province, China, reported a 19.6% infection rate among 204 diarrheal samples using RT-PCR [2]. In contrast, metagenomic surveys in Colombia detected BKV in over half of the sampled cattle, highlighting the potential for high circulation rates in certain production systems [3]. The virus is frequently co-detected with other enteric pathogens, including Enterovirus E and bovine astrovirus, complicating the attribution of clinical disease solely to BKV infection [3].

The World Organisation for Animal Health (WOAH) recognizes the importance of monitoring emerging viral pathogens in livestock, and the increasing documentation of BKV in multiple countries underscores the need for standardized surveillance protocols. From a One Health perspective, the close genetic relationship between bovine, porcine, and caprine kobuviruses raises questions about zoonotic potential, although no direct evidence of human infection with BKV has been reported to date. The Food and Agriculture Organization (FAO) and the World Health Organization (WHO) have emphasized the importance of characterizing the virome of livestock to anticipate and mitigate emerging infectious disease threats, and BKV represents a pertinent example of a virus that may have been underdiagnosed prior to the advent of metagenomic sequencing technologies.

Implications for Diagnostics and Vaccine Development

The genetic diversity of BKV poses challenges for diagnostic assay design and vaccine development. The identification of genotype B as the predominant lineage in China, with distinct sublineages circulating in other regions, necessitates the use of broadly reactive primers or probes targeting conserved genomic regions such as the 3D polymerase gene [1, 2]. The development of quantitative RT-PCR assays, as demonstrated for other bovine RNA viruses, could enhance the sensitivity and specificity of BKV detection, particularly in subclinical infections [4, 5]. Furthermore, the isolation of BKV in cell culture, such as the successful propagation of Yunnan strains in Vero cells, provides a foundation for future pathogenesis studies and vaccine candidate evaluation [2]. The high conservation of VP0 and VP3 across strains suggests that these structural proteins may be suitable targets for subunit or virus-like particle vaccines, though the variability in VP1 and the L protein must be considered to ensure broad coverage [2].

In summary, bovine kobuvirus is a genetically diverse picornavirus with a global distribution and a broadening host range that includes cattle, goats, and sheep. Its taxonomic placement within the genus Kobuvirus is well established, and ongoing genomic surveillance continues to refine our understanding of its evolutionary dynamics and epidemiological significance. The integration of metagenomic approaches into veterinary diagnostic workflows will be essential for elucidating the true prevalence, clinical impact, and transmission ecology of BKV, thereby informing evidence-based control strategies.

Genomic Structure and Phylogenetic Diversity of Bovine Kobuvirus

Bovine kobuvirus (BKV) is a non-enveloped, single-stranded positive-sense RNA virus belonging to the genus Kobuvirus within the family Picornaviridae. The genomic architecture of BKV is characteristic of picornaviruses, yet it possesses distinct features that underpin its evolutionary trajectory, host tropism, and pathogenic potential. Comprehensive genomic sequencing and phylogenetic analyses have revealed that BKV circulates as multiple genotypes across diverse geographic regions, exhibiting substantial nucleotide and amino acid variability that has profound implications for diagnostic assay design, vaccine development, and our understanding of cross-species transmission dynamics.

2.1 Genome Organization and Structural Features

The BKV genome typically ranges from approximately 8,139 to 8,291 nucleotides in length, as determined from complete genome sequences of caprine and bovine isolates [1, 2]. The genome contains a single open reading frame (ORF) encoding a polyprotein of approximately 2,480 amino acids, which is subsequently cleaved into structural and nonstructural proteins [1]. The genomic organization follows the canonical picornavirus layout: 5′ untranslated region (UTR), leader protein (L), structural proteins (VP0, VP3, VP1), and nonstructural proteins (2A–2C and 3A–3D), followed by the 3′ UTR and a poly(A) tail [2, 6].

The 5′ UTR of BKV is notably longer and more complex than that of many other picornaviruses, containing extensive secondary structures essential for internal ribosome entry site (IRES)-mediated translation initiation. Comparative genomic analyses have demonstrated that the 5′ UTR exhibits lower conservation than the 3′ UTR, suggesting that regulatory variations in the 5′ region may contribute to differential translational efficiency and host adaptation [2]. This observation aligns with findings from other kobuviruses, where the 5′ UTR is a hotspot for genetic variation that may influence virulence and tissue tropism.

The leader (L) protein of BKV is a distinctive feature of kobuviruses and is not found in all picornavirus genera. The L protein is the most variable region across BKV strains, with nucleotide and amino acid similarities as low as 94.7–95.2% when compared to reference strains [2]. This hypervariability suggests that the L protein may be under selective pressure from host immune responses or may play a role in modulating host cell signaling pathways to facilitate viral replication. Functional studies of the L protein in related kobuviruses have implicated it in the inhibition of host protein synthesis and the modulation of innate immune responses, although direct evidence for BKV remains limited.

The structural proteins VP0, VP3, and VP1 form the icosahedral capsid and are critical for receptor binding, cell entry, and antigenicity. Among these, VP1 is the most exposed on the virion surface and is therefore the primary target for neutralizing antibodies. Genetic analyses have revealed that VP1 exhibits considerable sequence diversity, with nucleotide substitutions accumulating at a higher rate than in other structural proteins [1]. In a study of caprine kobuvirus, 101 nucleotide substitutions were identified in the VP1 gene compared to only 35 substitutions in the 3D gene, underscoring the differential evolutionary constraints acting on structural versus nonstructural regions [1]. This variability in VP1 has important implications for serological diagnostics and vaccine design, as antigenic drift may reduce the efficacy of immune-based detection methods and cross-protection.

The nonstructural proteins, including the RNA-dependent RNA polymerase (3D), are generally more conserved across BKV strains. The 3D region exhibits nucleotide identities of 89–97% between ovine and bovine kobuviruses, reflecting the essential enzymatic functions that are subject to strong purifying selection [6]. The high conservation of the 3D region has made it a preferred target for molecular diagnostic assays, including reverse transcription PCR (RT-PCR) and quantitative RT-PCR (RT-qPCR), as primers designed against this region are likely to detect a broad range of BKV variants [6, 7].

2.2 Genotypic Classification and Global Distribution

Phylogenetic analyses based on complete genome sequences and partial gene regions (particularly VP1 and 3D) have consistently demonstrated that BKV strains cluster into two major genotypes, designated genotype A and genotype B [2]. Genotype B is the dominant genotype circulating in China and has been identified as the most prevalent genotype globally [2]. Strains belonging to genotype B, such as BKV YN-1 2023 and YN-2 2023 isolated from diarrheic cattle in Yunnan Province, China, exhibit genome-wide nucleotide identities ranging from 39.9% to 93.9% when compared to other BKV strains, with the highest similarity to the Chinese reference strain BKV 13/2021 [2]. This wide range of genetic diversity within genotype B indicates that multiple sublineages are co-circulating, potentially driven by geographic isolation, host immune pressure, and recombination events.

The genetic diversity of BKV is further exemplified by comparisons between bovine, caprine, and ovine kobuviruses. Whole-genome sequencing of a caprine kobuvirus from Minnesota (MN604700) revealed a genome of 8,139 nucleotides with 93% nucleotide identity to the caprine kobuvirus reference strain [1]. Phylogenetic analysis unexpectedly placed this caprine strain in a clade more closely related to porcine kobuviruses than to bovine or ovine kobuviruses [1]. This finding challenges the assumption that kobuvirus evolution strictly follows host species boundaries and suggests that cross-species transmission events may have occurred historically, potentially facilitated by shared agricultural environments or intermediate hosts.

The detection of kobuvirus in sheep further complicates the phylogenetic landscape. A study from Hungary identified ovine kobuvirus strain TB3-HUN in fecal samples from healthy lambs, with the partial 3D/3′ UTR region exhibiting 89% nucleotide and 97% amino acid identity to bovine kobuvirus [6]. Phylogenetic analysis placed the ovine strain within the same lineage as bovine kobuviruses but in a distinct sublineage, raising important questions about host specificity and the potential for bidirectional transmission between cattle and sheep [6]. The high prevalence (62.5%) of kobuvirus in young, healthy sheep suggests that sheep may serve as a natural reservoir or that the virus is endemic in sheep populations, with implications for BKV epidemiology in mixed-species farming systems.

2.3 Evolutionary Dynamics and Selection Pressures

The evolutionary dynamics of BKV are shaped by a combination of factors, including high mutation rates inherent to RNA viruses, recombination, host immune selection, and population bottlenecks during transmission. The RNA-dependent RNA polymerase of picornaviruses lacks proofreading activity, resulting in estimated mutation rates of approximately 10⁻³ to 10⁻⁵ substitutions per nucleotide per replication cycle. This high mutation rate generates substantial genetic diversity within infected hosts, enabling rapid adaptation to changing environments and immune pressures.

Comparative genomic analyses have revealed that the L protein and VP1 are under the strongest positive selection, as evidenced by elevated ratios of nonsynonymous to synonymous substitutions (dN/dS) in these regions [2]. In contrast, the nonstructural proteins, particularly 3D and 2C, are under strong purifying selection, reflecting functional constraints that limit amino acid changes [6]. The differential selection pressures across the genome have practical implications: diagnostic assays targeting conserved regions (e.g., 3D) are more likely to detect divergent strains, while assays targeting variable regions (e.g., VP1) may fail to detect emerging variants but can provide higher resolution for phylogenetic and epidemiological studies.

Recombination is another important driver of kobuvirus evolution, although its role in BKV diversification is less well characterized than for other picornaviruses such as enteroviruses. Evidence for recombination in kobuviruses comes from phylogenetic incongruence between different genomic regions and the detection of mosaic genomes in some strains. Recombination can facilitate the exchange of antigenic determinants, allowing viruses to escape host immunity while maintaining essential replicative functions. The potential for recombination between bovine, caprine, and porcine kobuviruses is particularly concerning in regions where multiple host species are raised in close proximity, as this could generate novel chimeric viruses with altered host range or pathogenicity.

2.4 Geographic and Temporal Patterns of Genetic Diversity

The geographic distribution of BKV genotypes exhibits distinct patterns that reflect both historical viral dissemination and contemporary livestock trade networks. In China, genotype B is the dominant circulating genotype, with strains from Yunnan Province showing close genetic relationships to strains from other Chinese provinces, suggesting a common origin and subsequent spread through domestic cattle movements [2]. The detection of BKV in 19.6% of diarrheic samples from Yunnan indicates that the virus is endemic in this region, with continuous circulation and evolution over time [2].

In Europe, kobuvirus strains from cattle, sheep, and pigs exhibit a complex phylogenetic structure that suggests multiple introductions and cross-species transmission events. The ovine strain TB3-HUN from Hungary clustered with bovine kobuviruses but formed a distinct sublineage, indicating that sheep may harbor a unique kobuvirus lineage that is closely related to, but genetically distinct from, bovine strains [6]. Similarly, porcine kobuvirus strains from Hungary and China form a separate clade within the kobuvirus genus, with nucleotide homologies of 73% and 70% to bovine kobuvirus and Aichi virus, respectively [7]. The genetic distance between porcine and bovine kobuviruses is sufficient to warrant classification as separate species within the genus, yet the close phylogenetic relationship suggests a common ancestor within the relatively recent evolutionary past.

The first report of BKV in Colombia, detected through viral metagenomics in 52% of fecal samples from cattle in Ubaté Province, highlights the global distribution of this virus and its emergence in regions where it was previously unrecognized [3]. Phylogenetic analysis of Colombian BKV sequences grouped them with samples from Asia and Latin America, underscoring the importance of adequate geographic representation in phylogenetic studies to accurately reconstruct viral spread and evolution [3]. The high prevalence of BKV in Colombian cattle, combined with the detection of other enteric viruses such as Enterovirus E and bovine astrovirus, suggests that BKV is an integral component of the bovine enteric virome and may contribute to the pathogenesis of diarrheal disease in complex co-infection scenarios.

2.5 Implications for Diagnostics, Vaccines, and Pathogenesis Research

The genomic diversity of BKV presents both challenges and opportunities for the development of diagnostic tools and control strategies. Molecular diagnostic assays, particularly RT-PCR and RT-qPCR, are the primary methods for BKV detection due to their high sensitivity and specificity. However, the genetic variability of BKV, especially in the VP1 region, means that primer and probe designs must target highly conserved regions to ensure broad reactivity across genotypes. The 3D region has emerged as the preferred target for generic kobuvirus screening, as primers designed against this region can detect bovine, porcine, ovine, and human kobuviruses [6, 7]. Nevertheless, the continuous evolution of BKV necessitates periodic reassessment of primer binding sites to avoid diagnostic failure due to nucleotide mismatches.

The development of effective vaccines against BKV is hampered by the lack of well-characterized serotypes and the limited understanding of protective immune responses. The antigenic diversity of VP1, which is the primary target for neutralizing antibodies, suggests that a monovalent vaccine based on a single strain may not provide broad protection against heterologous BKV genotypes. Future vaccine development efforts should focus on identifying conserved antigenic epitopes that elicit cross-protective immunity, potentially through the use of consensus sequences or multivalent formulations.

From a pathogenesis perspective, the genetic determinants of BKV virulence remain poorly defined. The hypervariability of the L protein, which is implicated in host immune modulation, suggests that this region may be a key virulence factor. Comparative genomic analyses of BKV strains from diarrheic and asymptomatic cattle could identify specific amino acid substitutions associated with increased pathogenicity, providing insights into the molecular mechanisms of disease. Additionally, the detection of BKV in healthy animals [6] indicates that subclinical infections are common, and that host factors, co-infections, or environmental stressors may influence the clinical outcome of infection.

In conclusion, the genomic structure and phylogenetic diversity of bovine kobuvirus reflect a dynamic and evolving pathogen that is widely distributed across global cattle populations. The virus exhibits substantial genetic variability, particularly in the L protein and VP1 regions, driven by high mutation rates and positive selection. Phylogenetic analyses have identified two major genotypes, with genotype B being the most prevalent globally, and have revealed complex relationships between bovine, caprine, ovine, and porcine kobuviruses that suggest historical cross-species transmission events. The continuous evolution of BKV poses challenges for diagnostics and vaccine development, but also provides opportunities for molecular epidemiological surveillance and the study of viral adaptation to new hosts and environments. Ongoing genomic surveillance, combined with functional studies of viral proteins, will be essential for understanding the evolutionary trajectory of BKV and for developing effective strategies to mitigate its impact on cattle health and productivity.

Molecular Pathogenesis of Bovine Kobuvirus Infection

The molecular pathogenesis of Bovine Kobuvirus (BKV) represents a complex interplay between viral genomic architecture, host cellular machinery, and the intricate microenvironment of the bovine gastrointestinal tract. As a member of the Picornaviridae family, genus Kobuvirus, BKV exhibits a single-stranded, positive-sense RNA genome of approximately 8.2–8.4 kb, organized into a single open reading frame (ORF) encoding a polyprotein of roughly 2,480 amino acids [1, 2]. This polyprotein is subsequently cleaved into structural proteins (VP0, VP3, VP1) and nonstructural proteins (2A–2C and 3A–3D), each playing distinct roles in viral replication, host cell manipulation, and immune evasion [6]. The leader (L) protein, unique to kobuviruses, is a critical determinant of pathogenesis, exhibiting the lowest sequence conservation among BKV strains (94.7–95.2% amino acid identity) yet harboring functional domains that antagonize host innate immune responses [2]. Understanding the molecular mechanisms by which BKV establishes infection, induces cytopathology, and disseminates within the bovine host is essential for developing targeted interventions and comprehending its role as an emerging enteric pathogen.

Genomic Architecture and Polyprotein Processing as Determinants of Virulence

The BKV genome is flanked by highly structured 5′ and 3′ untranslated regions (UTRs) that regulate translation and replication. Notably, the 5′ UTR exhibits significantly lower conservation than the 3′ UTR across circulating strains, suggesting that regulatory variations in this region may influence translational efficiency and tissue tropism [2]. The 5′ UTR contains an internal ribosome entry site (IRES) that cap-independently recruits host ribosomes, a feature common to picornaviruses that allows efficient translation even when host cap-dependent translation is shut off during infection. The polyprotein is co- and post-translationally processed by viral proteases, primarily 3Cpro and 2Apro, which cleave at specific dipeptide junctions. The L protein, positioned at the N-terminus of the polyprotein, is liberated early during translation and functions as a papain-like cysteine protease that cleaves itself from the nascent polypeptide. Beyond its proteolytic activity, the L protein of BKV is hypothesized to interfere with host nucleocytoplasmic trafficking and interferon signaling, analogous to the L proteins of other picornaviruses such as foot-and-mouth disease virus (FMDV). The high genetic variability observed in the L protein across BKV genotypes (94.7–95.2% similarity) [2] may reflect adaptation to different host environments or immune pressures, potentially modulating the severity of enteric disease.

The structural proteins VP0, VP3, and VP1 assemble into an icosahedral capsid that mediates receptor attachment and cell entry. VP1 is the most surface-exposed and immunodominant protein, containing the major neutralizing epitopes and receptor-binding sites. Comparative genomic analyses have revealed that VP1 exhibits the highest nucleotide substitution rate among BKV genes, with 101 nucleotide substitutions identified between closely related caprine kobuvirus strains [1]. This hypervariability in VP1 is a hallmark of picornavirus evolution, driven by selective pressure from host antibody responses and receptor specificity. The VP0 protein, which remains uncleaved in kobuviruses (unlike in enteroviruses where it is cleaved into VP4 and VP2), is thought to play a role in capsid stability and genome release during uncoating. The VP3 protein, together with VP0 and VP1, forms the capsid shell and contributes to antigenic diversity. The nonstructural proteins, including 2A, 2B, 2C, 3A, 3B (VPg), 3Cpro, and 3Dpol (RNA-dependent RNA polymerase), orchestrate genome replication, polyprotein processing, and host cell remodeling. The 3Dpol region is relatively conserved (77–84% amino acid identity between BKV and other kobuviruses) [6], making it a reliable target for molecular detection and phylogenetic classification. However, even within this conserved region, 35 nucleotide substitutions were observed between caprine kobuvirus strains [1], underscoring the ongoing evolutionary dynamics of these viruses.

Receptor Tropism and Cellular Entry Mechanisms

The molecular basis of BKV cellular tropism remains incompletely characterized, but structural homology with other picornaviruses suggests that VP1 interacts with specific cell surface receptors to initiate infection. In the bovine host, BKV exhibits a predilection for intestinal epithelial cells, particularly enterocytes lining the villi of the small and large intestines. The virus has been successfully isolated and propagated in Vero cells (African green monkey kidney epithelial cells), indicating that the receptor(s) utilized by BKV are conserved across mammalian species [2]. This broad cellular permissiveness is consistent with the detection of BKV in multiple ruminant hosts, including cattle, goats, and sheep [1, 6]. The identification of BKV in sheep with high nucleotide identity (89% in the 3D/3′ UTR region) to bovine kobuviruses [6] raises important questions about cross-species transmission and receptor usage. The close phylogenetic relationship between ovine and bovine kobuvirus strains suggests that these viruses may utilize a common receptor, potentially a glycoprotein or integrin expressed on the surface of ruminant intestinal epithelial cells. The ability of BKV to infect and replicate in diverse ruminant species has significant implications for the epidemiology and control of kobuvirus infections, as interspecies transmission may facilitate the emergence of novel strains with altered pathogenic potential.

Following receptor binding, BKV is internalized via clathrin-mediated endocytosis or macropinocytosis, depending on the specific receptor engagement. The acidic environment of the endosome triggers conformational changes in the capsid, leading to the release of the viral genome into the cytoplasm. The VPg protein, covalently linked to the 5′ end of the genomic RNA, serves as a primer for RNA replication by the 3Dpol. The replication complex assembles on modified host membranes, likely derived from the endoplasmic reticulum or Golgi apparatus, creating a protected microenvironment for viral RNA synthesis. The nonstructural protein 2B, known to form viroporins in other picornaviruses, may disrupt calcium homeostasis and membrane permeability, contributing to cytopathic effects and cell death. The 3A protein anchors the replication complex to membranes and may also modulate host secretory pathways, potentially interfering with antigen presentation and cytokine secretion.

Cytopathic Mechanisms and Intestinal Pathophysiology

The hallmark of BKV infection in cattle is acute or chronic diarrhea, particularly in young calves, although the virus is also frequently detected in asymptomatic animals [2, 3]. The molecular mechanisms underlying BKV-induced diarrhea are multifactorial and involve direct viral cytopathology, disruption of intestinal barrier function, and activation of inflammatory cascades. Upon infection of enterocytes, BKV replication induces cellular stress responses, including endoplasmic reticulum stress and the unfolded protein response, which can trigger apoptosis or necroptosis. The release of viral progeny from infected cells is accompanied by the loss of absorptive enterocytes, leading to villous atrophy and malabsorptive diarrhea. The nonstructural protein 2C, which possesses helicase and ATPase activities, may also contribute to membrane remodeling and the formation of cytoplasmic vesicles that disrupt normal cellular architecture.

Beyond direct cell lysis, BKV infection compromises the integrity of the intestinal epithelial barrier by disrupting tight junction proteins, such as occludin and claudins. This increased paracellular permeability allows the leakage of fluid and electrolytes into the intestinal lumen, exacerbating diarrheal disease. The viral L protein and 3Cpro may directly cleave or degrade host proteins involved in maintaining cell-cell junctions, a strategy employed by several enteric viruses to facilitate viral spread and enhance pathogenesis. Additionally, the influx of luminal contents into the subepithelial space triggers an inflammatory response characterized by the recruitment of neutrophils, macrophages, and lymphocytes. The release of pro-inflammatory cytokines, including interleukin-6 (IL-6), IL-8, and tumor necrosis factor-alpha (TNF-α), further amplifies tissue damage and contributes to the clinical manifestations of diarrhea, dehydration, and metabolic acidosis.

The observation that BKV is frequently detected in co-infections with other enteric pathogens, such as Enterovirus E, Bovine Astrovirus, and Bovine Coronavirus [3], suggests that BKV may act synergistically with other viruses to exacerbate disease severity. Viral metagenomic studies have revealed that BKV is present in a substantial proportion of diarrheic cattle (19.6–52% prevalence depending on geographic region) [2, 3], indicating that it is a common component of the bovine enteric virome. The high prevalence of BKV in both diarrheic and healthy animals [6] suggests that host factors, including age, immune status, microbiome composition, and co-infections, modulate the outcome of infection. Young calves, with their immature immune systems and developing gut microbiota, are particularly susceptible to BKV-associated diarrhea, while adult cattle may harbor the virus asymptomatically, serving as reservoirs for transmission.

Immune Evasion Strategies and Host Interactions

BKV has evolved sophisticated mechanisms to evade the host innate immune response, facilitating persistent infection and viral shedding. The L protein, as noted, is a key virulence factor that antagonizes interferon (IFN) signaling. In other picornaviruses, the L protein inhibits the expression of type I IFN by blocking the activation of interferon regulatory factor 3 (IRF3) and nuclear factor kappa B (NF-κB). The L protein of BKV likely employs similar strategies, possibly by targeting the retinoic acid-inducible gene I (RIG-I) or melanoma differentiation-associated protein 5 (MDA5) pathways, which are critical for sensing viral RNA and initiating the antiviral response. The 3Cpro protease also contributes to immune evasion by cleaving host proteins involved in innate immunity, including RIG-I, MDA5, and mitochondrial antiviral signaling protein (MAVS). This dual-pronged attack on the interferon system allows BKV to replicate efficiently in intestinal epithelial cells despite the presence of pattern recognition receptors.

The high genetic diversity of BKV, particularly in the VP1 and L protein regions, enables the virus to escape neutralizing antibody responses. The error-prone nature of the RNA-dependent RNA polymerase (3Dpol) generates a quasispecies population, allowing rapid adaptation to selective pressures from the host immune system. This genetic plasticity is evident in the phylogenetic analyses of BKV strains from different geographic regions, which cluster into distinct genotypes (e.g., genotype B in China) with nucleotide identities ranging from 39.9% to 93.9% across the genome [2]. The emergence of novel BKV strains, such as those identified in goats in Minnesota [1] and sheep in Hungary [6], highlights the ongoing evolution and host range expansion of kobuviruses. The World Organisation for Animal Health (WOAH) recognizes the importance of monitoring emerging enteric viruses like BKV, as their potential for cross-species transmission and zoonotic spillover cannot be discounted, particularly given the close genetic relationship between bovine and porcine kobuviruses and the association of Aichi virus (a human kobuvirus) with gastroenteritis [6, 7].

The role of the gut microbiome in modulating BKV pathogenesis is an emerging area of research. The intestinal microbiota influences the susceptibility to enteric viral infections through multiple mechanisms, including competitive exclusion, production of antiviral metabolites, and modulation of host immune responses. Disruption of the gut microbiota, as occurs during antibiotic treatment or dietary changes, may predispose calves to BKV infection and more severe disease. Conversely, BKV infection itself may alter the composition of the gut microbiota, creating a dysbiotic state that perpetuates intestinal inflammation and diarrhea. Understanding these complex host-microbe-virus interactions is crucial for developing probiotic or prebiotic interventions to mitigate BKV-associated disease in cattle.

Epidemiology and Prevalence of Bovine Kobuvirus in Global Cattle Populations

Bovine kobuvirus (BKV), a member of the genus Kobuvirus within the family Picornaviridae, has emerged as a subject of increasing veterinary and epidemiological significance over the past two decades. Initially identified in 2003 in apparently healthy cattle in Japan, BKV has since been documented across multiple continents, revealing a complex epidemiological landscape characterized by high prevalence rates in diarrheic cattle populations, substantial genetic diversity among circulating strains, and evidence of interspecies transmission events that challenge our understanding of host specificity and viral ecology. The global distribution of BKV, coupled with its consistent association with enteric disease in cattle, mandates a comprehensive epidemiological characterization to inform surveillance strategies, diagnostic approaches, and potential intervention measures.

Geographic Distribution and Prevalence Metrics

The epidemiological footprint of bovine kobuvirus now spans Asia, Europe, and the Americas, with prevalence rates varying considerably according to geographic region, diagnostic methodology, and the clinical status of sampled populations. In China, where BKV research has been particularly active, recent investigations have substantially advanced our understanding of the virus’s prevalence and genetic diversity. A pivotal study conducted in Yunnan Province, China, involving 204 diarrheal samples collected from cattle farms across five distinct regions, employed RT-PCR screening and revealed a BKV infection rate of 19.6% (40 positive samples) [2]. This finding is particularly noteworthy as it establishes a baseline prevalence for BKV in a region where limited prior data existed, and it underscores the virus’s role as a significant pathogen in diarrheic cattle populations. Importantly, whole-genome sequencing of two isolated strains, designated BKV YN-1 2023 and YN-2 2023, demonstrated genome lengths of 8,289 bp and 8,291 bp, respectively, with phylogenetic analysis confirming that both strains belong to genotype B, the dominant genotype circulating in China [2]. This genotypic predominance suggests a sustained epidemiological lineage that may possess adaptive advantages facilitating its widespread dissemination across Chinese cattle populations.

The prevalence of BKV is not confined to Asia; the virus has been documented with striking frequency in South America. A landmark viral metagenomic study conducted in Ubaté Province, Colombia, the nation’s dairy capital and a critical hub for livestock production, analyzed 42 fecal samples collected from three municipalities using Oxford Nanopore Technologies sequencing [3]. The results were remarkable: BKV was detected in 52% of sampled cattle, making it the second most frequently identified virus after Enterovirus E (59%) and surpassing Bovine Astrovirus (19%) [3]. This high prevalence in a geographically distinct region of Latin America underscores the global distribution of BKV and suggests that the virus may be endemic in cattle populations across diverse ecological and management systems. The Colombian study is particularly significant as it represents the first report of BKV in Colombia, filling a critical gap in our understanding of the virus’s distribution in South America and highlighting the utility of metagenomic sequencing techniques for comprehensive epidemiological surveillance [3].

In North America, evidence of kobuvirus circulation in ruminant populations has emerged from investigations in goats, providing important comparative data for understanding the broader kobuvirus epidemiology. A study conducted in Minnesota detected caprine kobuvirus in diarrheic kids over a two-year period, with findings suggesting an endemic state in the sampled goat population [1]. While this research focused on caprine hosts, the genomic characterization revealed that the caprine kobuvirus strain (MN604700) was most closely related to porcine kobuviruses rather than bovine or ovine kobuviruses, with nucleotide substitutions distributed across the genome resulting in 93% identity to the caprine reference strain [1]. This phylogenetic relationship raises intriguing questions about cross-species transmission dynamics and the evolutionary history of kobuviruses among livestock species, particularly given the potential for shared grazing, water sources, or management practices that could facilitate interspecies viral exchange.

Genetic Diversity and Phylogenetic Considerations

The genetic architecture of BKV exhibits considerable variability that has profound implications for epidemiological surveillance, diagnostic test design, and vaccine development. The whole-genome analysis of BKV strains from Yunnan Province revealed that genome-wide nucleotide identities among isolates ranged from 39.9% to 93.9%, with the highest similarity observed between the Chinese isolates and the previously reported strain BKV13/2021 CHN [2]. This extraordinary range of genetic diversity, spanning nearly 54 percentage points, indicates that multiple distinct lineages or genotypes of BKV are co-circulating within cattle populations, potentially with different pathogenic potentials, transmission efficiencies, or host range capacities. The open reading frame (ORF) analysis demonstrated nucleotide and amino acid similarities ranging from 48.7% to 93.9% and 29.3% to 98.5%, respectively, further emphasizing the extensive genetic heterogeneity within the BKV species [2].

Comparative genomic analyses have identified specific regions of the BKV genome that exhibit differential conservation, which may reflect functional constraints or adaptive pressures. The structural proteins VP0 and VP3, as well as the nonstructural proteins, demonstrated high conservation (97.8–100% similarity) among Chinese isolates when compared to the BKV13/2021 CHN reference strain [2]. In contrast, the L protein exhibited the lowest similarity (94.7–95.2%), suggesting that this region may be under selective pressure or may tolerate greater genetic variation without compromising viral fitness [2]. Additionally, the 5′ untranslated region (UTR) showed lower conservation than the 3′ UTR, implying potential regulatory variations that could influence viral replication, translation efficiency, or host adaptation [2]. These genetic insights are critical for developing molecular diagnostic tools that can reliably detect diverse BKV strains across different geographic regions and for monitoring the emergence of novel variants that might evade detection or exhibit altered pathogenic properties.

Phylogenetic analyses have consistently demonstrated that BKV strains cluster into distinct genotypes, with genotype B emerging as the dominant lineage in China [2]. This pattern of genotypic dominance may reflect founder effects, selective advantages conferred by specific genetic signatures, or epidemiological linkages related to cattle trade routes and management practices. The close phylogenetic relationship between Chinese BKV isolates and the Korean strain BKV13/2021 CHN suggests transboundary circulation of viral strains across East Asia, likely facilitated by the international movement of cattle or contaminated livestock products [2]. Such cross-border dissemination patterns underscore the importance of coordinated regional surveillance programs to monitor BKV epidemiology and to implement timely control measures when necessary.

Host Range and Interspecies Transmission Dynamics

The epidemiological landscape of bovine kobuvirus is further complicated by evidence of interspecies transmission and the virus’s capacity to infect multiple ruminant hosts. Studies conducted in Hungary detected kobuvirus in domestic sheep with a prevalence of 62.5% (5 of 8 fecal samples from young, healthy lambs), and phylogenetic analysis of the partial 3D/3′ UTR region revealed that the ovine kobuvirus strain (TB3-HUN) had 89% nucleotide and 97% amino acid identities to bovine kobuvirus, forming the same lineage but a distinct sublineage [6]. This high genetic similarity between ovine and bovine kobuviruses raises fundamental questions about host specificity and viral ecology: can a highly similar kobuvirus be present in and pathogenic for two animal species (cattle and sheep), or does this observation reflect natural contamination from a shared environment? The authors of the Hungarian study noted that a cattle farm was located adjacent to the sampled sheep herd, providing a plausible mechanism for fecal-oral transmission of kobuvirus between these farm animals [6]. However, the high prevalence in young, healthy sheep and the phylogenetic sublineage position of the ovine strain suggest that sheep may serve as genuine hosts rather than passive reservoirs, analogous to the situation observed for other pathogens such as bluetongue virus, adenoviruses, and foot-and-mouth disease viruses that can infect multiple ruminant species [6].

The implications of interspecies transmission for BKV epidemiology are substantial. If sheep, goats, or other ruminants can serve as competent hosts and potential reservoirs for BKV, control programs targeting only cattle may be insufficient to eliminate the virus from mixed-species farming operations. The detection of kobuvirus in goats in Minnesota over a two-year period, with endemic patterns suggesting sustained circulation [1], further supports the concept that multiple ruminant species contribute to the maintenance and propagation of kobuviruses in agricultural settings. From an evolutionary perspective, the ability of kobuviruses to infect multiple host species may accelerate viral diversification through host-specific selective pressures, potentially leading to the emergence of strains with altered tissue tropism, virulence, or transmissibility.

Epidemiological Implications for Global Cattle Health

The prevalence data emerging from diverse geographic regions, ranging from 19.6% in diarrheic cattle in China [2] to 52% in cattle in Colombia [3], indicate that BKV is a common component of the bovine enteric virome and may represent a significant, though underrecognized, contributor to diarrheal disease in cattle populations worldwide. The World Organisation for Animal Health (WOAH) recognizes the importance of emerging pathogens in livestock, and the epidemiological patterns observed for BKV align with the criteria for an emerging infectious disease of veterinary significance. The association of BKV with diarrhea in cattle, as documented in multiple studies [2, 3], suggests that the virus may cause clinically meaningful disease that impacts animal welfare, growth performance, and economic productivity in both dairy and beef production systems. However, the detection of BKV in healthy animals in some studies [6] indicates that the virus may also circulate subclinically, complicating efforts to establish definitive causal relationships between infection and disease.

The high prevalence of BKV in neonatal and young animals, as observed in diagnostic samples [2] and metagenomic surveys [3], aligns with the typical epidemiological pattern for enteric viruses, which often target immature immune systems and exploit the vulnerability of young livestock. The two-year detection period reported in the Minnesota goat study [1] suggests that kobuviruses can establish endemic circulation within herds, with sustained transmission likely facilitated by environmental contamination, fecal-oral spread, and the continuous introduction of susceptible newborns. The public health implications of BKV circulation in livestock, while not fully elucidated, warrant attention within the One Health framework, given the genetic relatedness of bovine kobuvirus to Aichi virus, a human pathogen associated with acute gastroenteritis [6]. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have emphasized the importance of monitoring zoonotic potential in emerging animal viruses, and the kobuvirus genus, with its documented capacity to infect humans, cattle, pigs, sheep, and goats, represents a candidate for enhanced surveillance at the human-animal interface.

Clinical Manifestations and Disease Association in Diarrheic Cattle

The clinical significance of Bovine Kobuvirus (BKV) as an enteric pathogen in cattle has been a subject of increasing scrutiny, particularly as metagenomic surveillance has revealed its high prevalence in diarrheic fecal samples across diverse geographical regions. While BKV was initially identified in apparently healthy cattle, a growing body of evidence now implicates this picornavirus in the pathogenesis of neonatal and juvenile diarrhea, often in complex interplay with other enteric pathogens. Understanding the full spectrum of clinical manifestations, from subclinical shedding to acute diarrheal disease, is critical for accurate diagnosis, effective herd management, and the development of targeted intervention strategies.

Clinical Spectrum of BKV-Associated Enteritis

The clinical presentation of BKV infection in cattle is highly variable, ranging from asymptomatic shedding to severe, watery diarrhea that can be clinically indistinguishable from other viral enteritides. In young calves, the most frequently reported manifestation is acute-onset, non-hemorrhagic diarrhea, often accompanied by dehydration, lethargy, and reduced suckling reflex. The severity of clinical signs appears to correlate with age, nutritional status, and the presence of concurrent infections. Epidemiological data from Yunnan Province, China, where a 19.6% infection rate was documented among 204 diarrheal samples, provide compelling evidence that BKV is a significant contributor to enteric disease in affected herds [2]. This prevalence rate is particularly noteworthy as it was derived from clinically affected animals, strengthening the association between viral detection and disease.

The pathophysiological mechanisms underlying BKV-induced diarrhea are not yet fully elucidated, but the virus’s tropism for intestinal epithelial cells is well established. As a member of the Picornaviridae family, BKV likely induces cytopathic effects in enterocytes, leading to villous atrophy, malabsorption, and osmotic diarrhea. The viral genome organization, featuring a single open reading frame encoding a polyprotein that is cleaved into structural (VP0, VP3, VP1) and nonstructural proteins, is typical of picornaviruses that replicate in the gastrointestinal tract [2]. The L protein, which shows the lowest genetic similarity among BKV strains (94.7–95.2% amino acid identity compared to other structural proteins), may play a role in host cell tropism and immune evasion, potentially influencing the clinical outcome of infection [2].

Age-Related Susceptibility and Disease Severity

Neonatal calves, particularly those under three weeks of age, appear to be the most susceptible to clinical disease. This age-related vulnerability is consistent with the epidemiology of other enteric picornaviruses, such as rotavirus and coronavirus, and is likely multifactorial. The immature immune system of the newborn calf, combined with the absence of a fully developed intestinal microbiota, creates a permissive environment for viral replication. Furthermore, the loss of passive immunity from colostrum, which wanes over the first few weeks of life, coincides with the peak incidence of BKV-associated diarrhea. In a study of caprine kobuvirus in Minnesota, the virus was detected in diarrheic kids over a two-year period, suggesting an endemic state in young ruminants that may mirror the situation in cattle [1]. The high genetic identity (93%) between the caprine strain and the reference strain, coupled with the identification of nucleotide substitutions in the VP1 and 3D genes, indicates that viral evolution is ongoing and may contribute to the emergence of strains with altered virulence or transmissibility [1].

The clinical course in affected calves typically follows a pattern of acute onset, with diarrhea persisting for 3–7 days in uncomplicated cases. However, in animals with concurrent infections or those raised under poor hygienic conditions, the disease can be more protracted and severe. Dehydration, metabolic acidosis, and electrolyte imbalances are common sequelae that require prompt supportive therapy. The economic impact of BKV-associated diarrhea is substantial, encompassing mortality, reduced weight gain, increased veterinary costs, and the labor associated with intensive nursing care.

Co-Infections and Synergistic Pathogenesis

One of the most critical aspects of BKV pathogenesis is its frequent occurrence as part of a polymicrobial enteric infection. Metagenomic studies have consistently demonstrated that BKV is rarely the sole pathogen identified in diarrheic fecal samples. In a comprehensive viral metagenomic survey conducted in Ubaté Province, Colombia, BKV was detected in 52% of fecal samples from cattle, but it was frequently co-detected with Enterovirus E (EVE, 59%) and Bovine Astrovirus (BoAstV, 19%) [3]. This high rate of co-infection complicates the attribution of clinical signs to BKV alone and suggests that synergistic interactions between these viruses may exacerbate disease severity.

The biological basis for this synergy is likely rooted in the disruption of intestinal barrier function. Primary infection with one enteric virus may compromise the integrity of the intestinal epithelium, facilitating the entry and replication of secondary pathogens. For instance, EVE, which was the most prevalent virus in the Colombian study, is known to cause cytopathic effects in intestinal cells, potentially creating a permissive environment for BKV replication [3]. Similarly, BoAstV, which was detected in 19% of samples, can induce mild enteritis on its own but may contribute to more severe disease when present in combination with BKV and EVE. The clinical implications of these co-infections are profound: animals harboring multiple viruses are more likely to present with severe, prolonged diarrhea, higher fever, and greater dehydration compared to those infected with BKV alone.

The presence of these co-infections also has diagnostic implications. Routine diagnostic panels that test for a limited number of pathogens (e.g., rotavirus, coronavirus, Escherichia coli K99) may miss BKV and other emerging viruses, leading to an incomplete understanding of the etiological agents responsible for a diarrheal outbreak. The adoption of metagenomic sequencing techniques, such as those employed by Medina et al. (2023) using Oxford Nanopore Technologies, offers a powerful tool for comprehensive pathogen detection and can reveal the true complexity of the enteric virome [3]. This approach is particularly valuable for identifying novel or unexpected pathogens and for monitoring the emergence of new viral variants.

Subclinical Shedding and Endemic Stability

While BKV is clearly associated with diarrheal disease, it is also important to recognize that subclinical shedding is common, particularly in older animals and in herds where the virus is endemic. The detection of BKV in healthy animals, as initially reported in the original identification of the virus in Japan, suggests that the virus can persist in the population without causing overt disease. This subclinical shedding plays a crucial role in the maintenance and transmission of the virus within and between herds. Calves that have recovered from acute infection may continue to shed virus in their feces for several weeks, serving as a source of infection for naïve pen mates. Similarly, adult cows, which are often asymptomatic, can act as reservoirs, intermittently shedding virus and perpetuating the cycle of infection.

The concept of endemic stability, where a high proportion of the population is immune and clinical disease is limited to susceptible young animals, is relevant to BKV epidemiology. In herds with high seroprevalence, maternally derived antibodies may protect calves during the first few weeks of life, but as these antibodies wane, the calves become susceptible. The timing of infection relative to the decay of maternal immunity determines whether the calf will develop clinical disease or experience a subclinical infection that boosts its own immune response. The findings of Sobhy et al. (2020), who detected caprine kobuvirus over a two-year period in Minnesota, suggest that an endemic state can become established in a population, with periodic outbreaks of disease occurring when a new cohort of susceptible animals is introduced [1].

Association with Other Clinical Syndromes

Beyond its role in enteric disease, there is emerging evidence that BKV may be associated with other clinical syndromes, although the data are currently limited. The virus has been detected in respiratory samples from cattle, raising the possibility that it may contribute to bovine respiratory disease complex (BRDC). However, the significance of this finding is unclear, as BKV is primarily considered an enteric pathogen. The detection of BKV in respiratory samples may reflect contamination from the gastrointestinal tract or may indicate that the virus has a broader tissue tropism than previously appreciated. Further research is needed to determine whether BKV can replicate in respiratory epithelial cells and whether it plays a causal role in respiratory disease.

There is no current evidence to suggest that BKV has zoonotic potential. While the closely related Aichi virus is known to cause gastroenteritis in humans, BKV is genetically distinct and has not been associated with human disease. The phylogenetic analysis of BKV strains from cattle, sheep, and goats indicates that these viruses form a distinct lineage within the Kobuvirus genus, separate from the human Aichi virus lineage [6]. This genetic divergence, particularly in the capsid proteins that determine host cell receptor binding, likely restricts the host range of BKV to ruminants. Nonetheless, continued surveillance is warranted, as the high mutation rate of RNA viruses could theoretically lead to the emergence of strains with altered host tropism.

Diagnostic Challenges and Clinical Decision-Making

The clinical diagnosis of BKV-associated diarrhea is challenging due to the non-specific nature of the clinical signs and the high frequency of co-infections. Watery diarrhea, dehydration, and depression are common to many enteric pathogens, and it is impossible to differentiate BKV from rotavirus, coronavirus, or cryptosporidiosis based on clinical examination alone. Therefore, laboratory confirmation is essential for an accurate diagnosis. Reverse transcription-polymerase chain reaction (RT-PCR) is the most sensitive and specific method for detecting BKV RNA in fecal samples, and it is the method of choice for both diagnostic and research purposes [2]. The development of quantitative RT-PCR assays allows for the quantification of viral load, which may be useful for assessing the clinical significance of a positive result. A high viral load in a diarrheic calf, particularly in the absence of other pathogens, is strongly suggestive of a causal role for BKV.

The isolation of BKV in cell culture, while possible, is more labor-intensive and less sensitive than molecular methods. Wang et al. (2025) successfully isolated two BKV strains (YN-1 2023 and YN-2 2023) from diarrheal samples by inoculating Vero cells and using immunofluorescence and electron microscopy for confirmation [2]. However, cell culture is not routinely used for diagnosis and is primarily reserved for research purposes, such as the characterization of viral isolates and the production of antigens for serological assays.

From a clinical management perspective, the treatment of BKV-associated diarrhea is primarily supportive. Fluid therapy to correct dehydration and electrolyte imbalances is the cornerstone of treatment, along with the provision of a clean, warm environment and continued access to milk or milk replacer. Antimicrobial therapy is not indicated for viral enteritis, but it may be necessary if secondary bacterial infections are suspected. The use of probiotics and other gut health modulators is an area of active research, but their efficacy in BKV infections has not been specifically evaluated. Prevention and control strategies should focus on improving hygiene, ensuring adequate colostrum intake, and minimizing stress in young calves. Vaccination against BKV is not currently available, but the genetic characterization of circulating strains, such as those belonging to genotype B in China, provides a foundation for future vaccine development [2].

Diagnostic Methods for Bovine Kobuvirus: Molecular, Serological, and Virological Approaches

The accurate and timely diagnosis of Bovine Kobuvirus (BKV) infection is paramount for understanding its epidemiology, assessing its clinical impact on cattle health, and implementing effective control strategies. As an emergent enteric pathogen of the Picornaviridae family, BKV presents unique diagnostic challenges due to its genetic diversity, the often subclinical nature of infections, and its frequent co-occurrence with other enteric viruses. The diagnostic armamentarium for BKV has expanded significantly over the past decade, evolving from basic reverse-transcription PCR (RT-PCR) to sophisticated metagenomic sequencing and traditional virological culture. This section provides a comprehensive, authoritative examination of these approaches, detailing their underlying principles, methodological nuances, performance characteristics, and specific applications in both research and clinical veterinary settings.

Molecular Diagnostic Approaches: The Cornerstone of BKV Detection

Molecular methods, particularly those based on the amplification of viral nucleic acids, constitute the primary and most sensitive tools for BKV detection. This predominance stems from the virus's RNA genome, its lack of a robust and standardized serological assay for routine screening, and the inherent difficulties in isolating the virus in cell culture. The molecular diagnostic landscape for BKV is diverse, ranging from broadly reactive screening assays to high-resolution genomic characterization.

Reverse Transcription-Polymerase Chain Reaction (RT-PCR) and Quantitative RT-PCR (qRT-PCR)

Conventional RT-PCR has been the workhorse for initial BKV detection and epidemiological screening. The design of primers is critical and has historically targeted highly conserved regions of the viral genome, most notably the 3D region encoding the RNA-dependent RNA polymerase (RdRp). Early studies, such as those identifying kobuvirus in sheep, utilized generic kobuvirus screening primers (UNIV-kobu-R/F) designed from alignments of Aichi virus, bovine kobuvirus, and porcine kobuvirus sequences to amplify a 216-nt fragment of the 3D region [6]. This approach demonstrated a high prevalence of kobuvirus in healthy sheep (62.5%), underscoring the utility of broadly reactive primers for detecting kobuvirus across different host species [6]. Similarly, the initial characterization of a candidate porcine kobuvirus in China relied on primers targeting the 3D region, yielding a 1,185-bp fragment that was phylogenetically informative [7]. For BKV specifically, RT-PCR has been extensively employed in prevalence studies. A recent large-scale investigation in Yunnan Province, China, used an RT-PCR-based screening approach on 204 diarrheal samples, identifying a 19.6% infection rate, which subsequently facilitated the successful isolation of two novel BKV strains [2].

However, the limitations of conventional RT-PCR, primarily its semi-quantitative nature and lower sensitivity, have led to the widespread adoption of quantitative RT-PCR (qRT-PCR). While the provided sources do not detail a BKV-specific qRT-PCR protocol, the principles established for other bovine viruses, such as the SYBR Green I-based assay for bovine ephemeral fever virus (BEFV), are directly transferable [4]. Such an assay for BKV would offer several advantages: it provides precise quantification of viral RNA load, which is crucial for studying viral kinetics, correlating viral burden with disease severity, and monitoring the efficacy of therapeutic or prophylactic interventions [4]. The analytical sensitivity of a well-optimized qRT-PCR is typically several orders of magnitude higher than conventional RT-PCR, as demonstrated for BEFV where the qRT-PCR was ~100 times more sensitive [4]. Furthermore, the high precision of qRT-PCR (with intra- and inter-assay coefficients of variation often <2%) ensures robust and reproducible data, essential for longitudinal studies and inter-laboratory comparisons [4]. The application of probe-based qRT-PCR (e.g., TaqMan) could further enhance specificity, eliminating the need for post-PCR processing and reducing the risk of cross-contamination. The selection of an appropriate endogenous control gene, such as peptidylprolyl isomerase A (PPIA) as identified for BEFV kinetics in cattle, is critical for accurate normalization in relative quantification studies [4].

PCR-Based Subtyping and Molecular Characterization

Beyond mere detection, molecular methods are indispensable for characterizing the genetic diversity and evolutionary dynamics of BKV. Sanger sequencing of amplicons from specific genomic regions provides a first-tier approach to molecular epidemiology. The 3D and VP1 (viral protein 1) genes are particularly informative targets. The VP1 gene, which encodes the major capsid protein, is the primary determinant of serotype and is under significant immune selection pressure, making it ideal for phylogenetic clustering and strain differentiation [1, 2]. In contrast, the 3D region is more conserved and useful for higher-level taxonomic assignments. For instance, in a study on caprine kobuvirus, Sanger sequencing of PCR products revealed that the 3D and VP1 genes of field strains were 95% and 91% identical, respectively, to the index strain, with 35 and 101 nucleotide substitutions identified in these regions, highlighting the greater variability in the structural VP1 gene [1]. In bovine kobuvirus, whole-genome and ORF-based analyses demonstrated that the L (leader) protein had the lowest similarity (94.7-95.2%) compared to other regions like VP0 and VP3 (97.8-100%), suggesting that the L protein might be a hotspot for genetic variation and potentially host adaptation [2].

Whole-Genome Sequencing (WGS) and Metagenomics

Whole-genome sequencing represents the most definitive molecular approach, providing a complete blueprint of the viral genome. This is critical for understanding recombination events, identifying virulence markers, and tracing transmission pathways. The complete genome of BKV is approximately 8.2-8.3 kb in length, encoding a single large open reading frame (ORF) [1, 2]. WGS has been pivotal in classifying BKV strains into distinct genotypes. For example, two BKV strains isolated in Yunnan, China, possessed genome lengths of 8,289 bp and 8,291 bp and were identified as belonging to genotype B, the dominant genotype circulating in China, demonstrating that WGS is essential for accurate genotype assignment [2]. The phylogenetic power of WGS allows for fine-scale discrimination that is impossible with partial gene sequences. Furthermore, WGS reveals key genomic features such as the lower conservation in the 5' untranslated region (UTR) compared to the 3' UTR, which may indicate regulatory variations affecting translation or replication efficiency [2].

Unbiased high-throughput sequencing, or viral metagenomics, has emerged as a revolutionary tool for pathogen discovery and surveillance. This approach circumvents the need for prior knowledge of the target pathogen's sequence, allowing for the detection of known and novel viruses simultaneously. In a landmark study of bovine fecal samples from Central Colombia, viral metagenomics using Oxford Nanopore Technologies (ONT) identified a high prevalence of BKV (52%), alongside other enteric viruses like Enterovirus E (EVE) and Bovine Astrovirus (BoAstV) [3]. This study was the first to report BKV in Colombia, highlighting the power of metagenomics to uncover the geographic distribution of emerging viruses [3]. Metatranscriptomic sequencing, a subset of metagenomics focusing on RNA, offers a direct method for detecting RNA viruses like BKV. However, its diagnostic performance is heavily influenced by sequencing depth and the choice of reference genome. A study on bovine respiratory RNA viruses demonstrated that sequencing at depths of ≥10 million reads was sufficient to detect viruses with high Ct values (up to 40) by qRT-PCR, but high genome completeness was only achievable for samples with lower Ct values (<30) [8]. Critically, the recovery of BVDV-1 reads was strongly dependent on the reference genome used; mapping to a study-assembled genome yielded far more reads than mapping to a distant NCBI RefSeq sequence, underscoring the problem of reference bias when dealing with genetically diverse field strains [8]. This finding is directly applicable to BKV diagnostics: a metagenomic pipeline must use a comprehensive, up-to-date database of BKV sequences to avoid false-negative results due to divergence from standard references.

Targeted Next-Generation Sequencing (tNGS)

As a bridge between single-target PCR and broad-range metagenomics, targeted next-generation sequencing (tNGS) offers a powerful, cost-effective compromise. tNGS uses a multiplexed panel of PCR primers to enrich for specific genomic regions of multiple pathogens prior to NGS. A study designed a panel of 198 primers targeting 43 common bovine and small-ruminant pathogens, including viruses, bacteria, fungi, and parasites [5]. This approach was validated on 60 clinical samples and was able to detect multiple pathogens simultaneously, including some that were missed by routine diagnostic techniques because the specific tests were not requested [5]. The detection limits were comparable to qRT-PCR, with the ability to detect organisms from samples with Ct values in the 30s [5]. For BKV, a custom tNGS panel could include primers for the conserved 3D region for broad detection, alongside primers for the variable VP1 region for intra-typing, all in a single reaction. This multiplexing capability is particularly valuable for enteric disease cases where coinfections with rotavirus, coronavirus, E. coli, or other agents are common.

Serological Approaches: Current Status and Future Potential

Serological diagnosis of BKV is currently not a routine diagnostic tool, and the provided sources do not describe a validated, commercially available enzyme-linked immunosorbent assay (ELISA) or virus neutralization test (VNT) for BKV. This is a significant gap in the diagnostic toolkit. The development of serological assays is critical for several reasons: they can detect past or current infection even after viral RNA is cleared, they are useful for large-scale seroprevalence studies to understand population-level exposure, and they are essential for assessing vaccine-induced immunity.

The absence of a standard BKV serological assay can be contrasted with the well-established serological methods for other bovine viral diseases. For example, the serological diagnosis of enzootic bovine leukosis (EBL) relies on agar gel immunodiffusion (AGID) and ELISA, both of which have been optimized and standardized according to WOAH recommendations [10]. The development of a BKV-specific ELISA would hinge on the expression of recombinant viral proteins, most likely the capsid proteins VP0, VP3, and VP1, which are the primary targets of the humoral immune response. The sequence conservation in VP0 and VP3 (97.8-100% for some BKV isolates) suggests that these could be used to develop a broadly reactive ELISA for detecting antibodies against diverse BKV strains [2]. Conversely, an assay based on the more variable VP1 could be used for serotyping.

The WOAH-recommended standard for serological diagnosis of bovine brucellosis, the complement fixation test (CFT), serves as the gold standard but is technically demanding and unsuitable for high-throughput screening [9]. In contrast, the Rose Bengal Plate Test (RBPT) is a simple, rapid screening test used for brucellosis [9, 11]. Similar principles could guide the development of a BKV serological strategy: a high-throughput ELISA for screening, followed by a confirmatory VNT to resolve ambiguous results. The validation of such an assay would require careful establishment of cut-off values using panels of well-characterized positive and negative sera, including samples from colostrum-fed calves to account for maternal antibody interference. The recent efforts to standardize control sera for BVDV diagnosis in Kazakhstan, where a domestic panel of standard blood sera was developed and validated against international standards, provide a valuable roadmap for BKV serology [12]. This highlights the importance of international collaboration and the use of reference materials to ensure inter-laboratory comparability [12].

Virological Approaches: Isolation and Characterization

Virus isolation in cell culture remains a cornerstone of classical virology, providing a live virus stock essential for detailed phenotypic characterization, pathogenesis studies, and vaccine development. The isolation of BKV, however, is notably challenging. Historically, the propagation of picornaviruses like kobuvirus has been difficult. Early attempts to isolate the candidate porcine kobuvirus in RD cells failed to produce a consistent cytopathic effect (CPE), and viral RNA signal decreased with each passage, suggesting poor or abortive replication [7].

Despite these challenges, recent advances have led to the successful isolation of BKV in Vero cells. A pivotal study reported the isolation of two BKV strains (YN-1 2023 and YN-2 2023) by inoculating Vero cells with RT-PCR-positive diarrheal samples and performing continuous blind passages [2]. The successful isolation was confirmed by a combination of molecular biology (RT-PCR), immunofluorescence (IFA) using BKV-specific antibodies, and transmission electron microscopy (TEM) [2]. TEM is a critical confirmatory step, as it allows for direct visualization of the characteristic picornavirus morphology: small (~30 nm), non-enveloped, icosahedral virions within infected cells [2]. The detection of BKV in cell culture using IFA depends on the availability of high-quality, specific antisera, which are often produced by immunizing laboratory animals with purified virus or recombinant structural proteins.

The use of Vero cells, a continuous cell line derived from African green monkey kidney, appears to be a key factor for successful isolation [2]. The protocol typically involves inoculating cell monolayers with a filtered fecal supernatant, followed by a 1-2 hour adsorption period. The inoculum is then removed, and fresh maintenance medium is added. Cells are monitored daily for the appearance of CPE, which for kobuviruses can be subtle or even absent, necessitating blind passages where cells and supernatants are harvested every 5-7 days and used to infect fresh monolayers. After several rounds of blind passage, the virus may adapt to cell culture, leading to more pronounced and consistent CPE, which manifests as cell rounding, detachment, and eventual lysis. The success of virus isolation is sample-dependent; samples with high viral loads (low Ct values in qRT-PCR) are more likely to yield an isolate. Even with successful isolation, the viral yield may be low, requiring concentration steps like ultracentrifugation or polyethylene glycol (PEG) precipitation for downstream applications.

Integrated Diagnostic Strategy and Method Selection

In a practical veterinary setting, the choice of diagnostic method depends on the specific objective. For initial outbreak investigation or prevalence screening, a sensitive and specific RT-PCR targeting the conserved 3D region is the most appropriate first-line test. If resources allow, a multiplex RT-PCR or tNGS panel that includes BKV and other common enteric pathogens (e.g., rotavirus, coronavirus, bovine viral diarrhea virus) would provide a more comprehensive etiological picture in a single test [5]. For research purposes, such as studying viral evolution or transmission dynamics, WGS of PCR-positive samples is mandatory. Metagenomics is the preferred approach for pathogen discovery in cases with a high index of suspicion for an unknown agent or for comprehensive virome surveillance in a herd [3, 8].

Serology, once validated, would be invaluable for herd-level screening and for monitoring the immune status of animals, particularly in vaccine trials. However, its current absence means that molecular detection is the sole reliable method for determining active infection.

Virus isolation is not a routine diagnostic tool due to its laborious nature, time requirement (weeks), and relatively low sensitivity. However, it remains essential for research applications: generating live virus for challenge studies, producing antigens for serological assay development, and conducting antiviral susceptibility testing. The successful isolation of BKV in Vero cells [2] represents a major methodological advance that should facilitate future research.

The evolving field of metatranscriptomics presents a promising future direction, but its reliance on high sequencing depth and appropriate reference genomes [8] currently limits its routine use. The integration of these methods, from initial molecular screening to high-resolution genomic characterization, provides a robust framework for the comprehensive study and management of Bovine Kobuvirus infections. The lack of a validated serological assay represents a critical knowledge gap that must be addressed to enable large-scale epidemiological studies and to assess the true extent of BKV circulation and its impact on bovine health globally.

Prevention, Control, and Future Research Directions for Bovine Kobuvirus

The development of effective prevention and control strategies for Bovine Kobuvirus (BKV) is confronted by a constellation of challenges that are both epidemiological and virological in nature. Unlike well-characterized bovine pathogens for which vaccines, eradication programs, and standardized diagnostic protocols exist, BKV remains an emerging agent whose clinical significance, transmission dynamics, and ecological niche are only beginning to be elucidated. The prevention and control of BKV must therefore be approached through a multi-layered framework that integrates biosecurity measures, enhanced surveillance infrastructure, diagnostic standardization, and a forward-looking research agenda aimed at filling critical knowledge gaps. The World Organisation for Animal Health (WOAH) has yet to issue specific recommendations for BKV, underscoring the urgency of generating the evidence base necessary for international guidance.

Biosecurity and Farm-Level Prevention

At the most fundamental level, the prevention of BKV introduction and spread within cattle populations hinges upon robust biosecurity protocols. Given that BKV is shed in feces and transmission is presumed to occur via the fecal-oral route, the same principles that govern the control of other enteric pathogens in livestock operations are applicable. The implementation of strict hygiene measures, including the regular cleaning and disinfection of housing facilities, feeding equipment, and water sources, constitutes the first line of defense. The efficacy of disinfectants against picornaviruses, including kobuviruses, is a critical consideration. The biocidal preparation “Crezonid” has demonstrated pronounced bactericidal activity against Escherichia coli and Staphylococcus aureus, with a minimum effective concentration of 0.5% and an exposure time of 30 minutes, and importantly, it exhibits minimal reduction in effectiveness under conditions of organic contamination typical of livestock facilities, as indicated by a protein index of 1.3–1.4 [18]. While this study did not specifically evaluate antiviral activity against BKV, the principles of disinfection efficacy in the presence of organic load are directly transferable. The selection of disinfectants with proven activity against non-enveloped viruses, combined with appropriate contact times and concentrations, is essential for breaking the chain of transmission.

Beyond environmental sanitation, the management of animal movements and the introduction of new stock represent critical control points. The purchase of animals from other farms has been identified as a significant risk factor for the introduction of infectious diseases in bovine herds [11]. For BKV, where subclinical shedding is likely common, the introduction of apparently healthy animals from herds of unknown BKV status poses a substantial risk. Quarantine protocols for newly arrived animals, ideally accompanied by diagnostic testing to confirm BKV-negative status, should be considered a standard preventive measure. The segregation of age groups, particularly the separation of young calves from adult cattle, may also reduce the intensity of exposure, as younger animals are often more susceptible to enteric infections. Furthermore, the disposal of manure and the management of slurry must be conducted in a manner that minimizes environmental contamination and the potential for mechanical transmission via fomites, equipment, and personnel.

Surveillance and Diagnostic Infrastructure

Effective control of BKV is impossible without a robust surveillance infrastructure capable of detecting the virus, monitoring its prevalence, and identifying emerging strains. Current data indicate that BKV is widely distributed across multiple continents, with detection rates varying considerably by region and sampling strategy. In Yunnan Province, China, a study of 204 diarrheal samples revealed an infection rate of 19.6% [2], while in central Colombia, viral metagenomics identified BKV in 52% of fecal samples from cattle [3]. These figures, while informative, likely represent underestimates of true prevalence due to the cross-sectional nature of sampling and the reliance on convenience sampling in many studies. The establishment of systematic, longitudinal surveillance programs that employ standardized diagnostic methods is a pressing need.

The diagnostic tools currently available for BKV detection are primarily based on reverse transcription PCR (RT-PCR) targeting conserved regions of the genome, such as the 3D polymerase gene. However, the genetic diversity of BKV strains, with nucleotide identities across the genome ranging from 39.9% to 93.9% [2], poses a significant challenge for primer design and assay sensitivity. The development and validation of quantitative real-time RT-PCR (RT-qPCR) assays with high analytical sensitivity and specificity are essential for both clinical diagnosis and research applications. The SYBR green I–based RT-qPCR assay developed for bovine ephemeral fever virus, which demonstrated analytical sensitivity approximately 100 times higher than conventional RT-PCR and high precision with intra-assay coefficients of variation of 0.23–0.89% [4], provides a methodological template that could be adapted for BKV. Similarly, the validation of a qPCR test kit for Mycoplasma dispar DNA, which achieved a detection limit of 10 copies/μL and 100% specificity [16], illustrates the rigorous validation parameters that should be applied to BKV diagnostic assays.

Beyond PCR-based methods, metagenomic sequencing approaches offer a powerful tool for surveillance, particularly for detecting co-infections and identifying novel or divergent strains. The use of viral metagenomics with Oxford Nanopore Technologies in Colombia successfully identified BKV alongside Enterovirus E and Bovine Astrovirus, demonstrating the utility of this approach for comprehensive virome characterization [3]. However, the sensitivity of metatranscriptomic sequencing is influenced by sequencing depth and reference genome choice. Studies on bovine respiratory viruses have shown that sequencing at ≥10 million reads is sufficient for detection of samples with high viral loads, but recovering high genome completeness requires samples with cycle threshold (Ct) values below 30 [8]. For BKV, where viral loads in feces may vary widely, the establishment of standardized protocols for sample preparation, sequencing depth, and bioinformatic analysis is necessary to ensure comparability across studies and laboratories. The targeted next-generation sequencing approach, which uses pathogen-specific primers to enrich genomic regions of interest, has shown promise for detecting multiple bovine pathogens simultaneously, including those missed by routine diagnostic techniques [5]. This approach could be adapted to create a multiplex panel that includes BKV alongside other enteric viruses, thereby increasing diagnostic efficiency and providing a more complete picture of the enteric virome.

Control Strategies and the Potential for Vaccination

The development of effective control strategies for BKV is hampered by the lack of a licensed vaccine. The path to vaccine development requires a comprehensive understanding of the immune response to BKV infection, including the identification of protective antigens and the correlates of immunity. The BKV genome encodes a single polyprotein that is cleaved into structural proteins (VP0, VP3, VP1) and nonstructural proteins (2A–2C, 3A–3D), preceded by a leader (L) protein [2]. Comparative genomic analyses have revealed that the L protein exhibits the lowest similarity among strains, with amino acid identities as low as 94.7–95.2% compared to the reference strain BKV13/2021 CHN, while the structural proteins VP0 and VP3, as well as the nonstructural proteins, are highly conserved (97.8–100%) [2]. This conservation suggests that the structural proteins, particularly VP0 and VP3, may serve as suitable targets for vaccine development, as they are likely to induce cross-protective immune responses against diverse BKV strains.

The VP1 protein, which in picornaviruses is typically the major immunodominant antigen and contains critical neutralization epitopes, showed lower conservation in the Yunnan isolates, with nucleotide substitutions observed compared to the reference strain [2]. This variability may reflect immune pressure and could complicate vaccine design if VP1 is the primary target. However, the high conservation of VP0 and VP3 offers alternative targets. The development of an inactivated whole-virus vaccine, similar to those used for foot-and-mouth disease virus (another picornavirus), is a feasible approach, provided that BKV can be reliably propagated in cell culture to sufficient titers. The isolation of BKV strains YN-1 2023 and YN-2 2023 in Vero cells, confirmed by immunofluorescence and electron microscopy [2], demonstrates that cell culture adaptation is achievable, though the efficiency of viral replication and the yields obtained require further optimization.

Live-attenuated vaccines, while potentially more immunogenic, carry the risk of reversion to virulence and are generally less favored for enteric pathogens due to the potential for shedding and environmental contamination. Subunit vaccines based on recombinant structural proteins, or virus-like particles (VLPs) produced in heterologous expression systems, represent a safer alternative. The identification of a target polypeptide for the CD169 receptor on bovine macrophages using phage display technology [13] opens the possibility of developing targeted vaccine delivery systems that enhance antigen presentation and immune activation. Such approaches could significantly improve the efficacy of BKV vaccines by directing antigens to professional antigen-presenting cells.

In the absence of a vaccine, control must rely on test-and-cull strategies, similar to those employed for bovine viral diarrhea virus (BVDV) eradication programs. The Irish BVD eradication program, which achieved a reduction in the prevalence of persistently infected (PI) calves from 0.66% in 2013 to 0.03% by the end of 2020 [14], provides a model that could be adapted for BKV, provided that the biological basis for persistent infection is established. Unlike BVDV, for which the existence of PI animals is a well-characterized phenomenon resulting from in utero infection before the development of immunocompetence, it is not yet known whether BKV can establish persistent infections in cattle. If BKV does not cause persistent infection, then test-and-cull strategies would be less effective, and control would need to focus on reducing transmission through biosecurity and management practices.

Future Research Directions: Filling Critical Knowledge Gaps

The future research agenda for BKV must prioritize several interconnected areas that are essential for the rational design of prevention and control strategies. First and foremost is the need to definitively establish the clinical significance of BKV infection. While BKV has been detected in diarrheic calves, the detection of the virus in healthy animals raises questions about its role as a primary pathogen versus a commensal or opportunistic agent. The detection of kobuvirus in healthy sheep at a prevalence of 62.5% [6] and in healthy piglets at 30.12% [7] suggests that subclinical infections are common across multiple host species. Controlled experimental infection studies in gnotobiotic or colostrum-deprived calves, with careful monitoring of clinical signs, viral shedding, and intestinal pathology, are necessary to fulfill Koch's postulates and determine whether BKV alone can induce diarrheal disease. Such studies should include histopathological examination of intestinal tissues to identify the cellular targets of BKV replication and the nature of the associated lesions.

The molecular epidemiology and evolutionary dynamics of BKV require sustained investigation. The identification of two distinct genotypes (A and B) and the predominance of genotype B in China [2] raises questions about the global distribution of these genotypes and their association with clinical outcomes. Large-scale, cross-sectional studies spanning multiple geographic regions, employing standardized genotyping protocols based on complete or near-complete genome sequences, are needed to map the phylogeography of BKV. The detection of kobuvirus in goats with 93% nucleotide identity to the caprine reference strain [1] and in sheep with 89% nucleotide identity to bovine kobuvirus [6] indicates that interspecies transmission may occur, particularly among ruminants sharing grazing lands or water sources. The potential for BKV to circulate among cattle, sheep, and goats has implications for control strategies, as eradication from one host species may be undermined by spillover from another. Longitudinal studies on mixed-species farms, combining viral sequencing with network analysis of animal movements and contacts, could elucidate the pathways of interspecies transmission.

The host range of BKV and its zoonotic potential are critical unanswered questions. Kobuviruses have been detected in humans (Aichi virus), pigs, cattle, sheep, goats, and rodents. The genetic relatedness between bovine and ovine kobuviruses [6] and between porcine and bovine kobuviruses [7] suggests that the genus Kobuvirus may have a broader host range than currently recognized. The detection of BKV in 52% of fecal samples from cattle in Colombia [3] raises the question of whether human populations in close contact with livestock, such as farm workers and their families, are exposed to BKV. Serological surveys using recombinant BKV antigens could determine the prevalence of antibodies in human populations with occupational exposure to cattle. If BKV is found to infect humans, even asymptomatically, it would have implications for public health surveillance and would necessitate a One Health approach to control.

The development of effective vaccines requires a deeper understanding of the immune response to BKV. Studies on the kinetics of antibody responses following natural infection or experimental challenge, including the characterization of neutralizing antibody titers and the duration of immunity, are needed. The identification of B-cell and T-cell epitopes on the structural and nonstructural proteins could inform the design of subunit vaccines and diagnostic assays that differentiate infected from vaccinated animals (DIVA). The use of phage display peptide libraries, as demonstrated for the identification of CD169-targeting peptides [13], could be applied to map the antigenic landscape of BKV and identify peptides that elicit protective immune responses.

Finally, the integration of BKV surveillance into existing national and international animal health monitoring systems is essential. The evaluation of laboratory diagnostic surveillance systems, as conducted for five cattle diseases in France using the OASIS method [15], provides a framework for assessing the strengths and weaknesses of current surveillance infrastructure and identifying areas for improvement. The development of syndromic surveillance algorithms that incorporate BKV testing data, similar to those developed for bovine laboratory test data in the United States [17], could enable early detection of outbreaks and facilitate rapid response. The establishment of a centralized database for BKV sequence data, linked to epidemiological metadata, would support real-time monitoring of viral evolution and the emergence of new strains. Such a database, modeled on the successful platforms used for influenza virus and SARS-CoV-2, would be an invaluable resource for the global veterinary community.

In conclusion, the prevention and control of Bovine Kobuvirus require a comprehensive, multi-disciplinary approach that integrates farm-level biosecurity, enhanced surveillance, diagnostic standardization, and a robust research agenda. The path forward is illuminated by the lessons learned from other bovine viral diseases, but the unique characteristics of BKV, its genetic diversity, its potential for interspecies transmission, and its uncertain clinical significance, demand dedicated investigation. Only through sustained investment in research and the translation of findings into practical control measures can the impact of this emerging pathogen on cattle health and productivity be

References

[1] Sobhy N, Armién A, Wünschmann A, Muldoon D, Goyal S, Mor S. Detection and molecular characterization of kobuvirus from diarrheic goats in Minnesota. Journal of Veterinary Diagnostic Investigation. 2020. DOI: https://doi.org/10.1177/1040638720949475

[2] Wang G, Deng Q, Zhu P, Punyapornwithaya V, Shi X, Liu Y, et al.. Genomic sequencing and evolutionary analysis of bovine kobuvirus in Yunnan Province, China. BMC Veterinary Research. 2025. DOI: https://doi.org/10.1186/s12917-025-04811-y

[3] Medina J, Castañeda S, Páez-Triana L, Camargo M, García-Corredor D, Gómez M, et al.. High prevalence of Enterovirus E, Bovine Kobuvirus, and Astrovirus revealed by viral metagenomics in fecal samples from cattle in Central Colombia.. Infection, Genetics and Evolution. 2023. DOI: https://doi.org/10.1016/j.meegid.2023.105543

[4] Gao S, Du J, Tian Z, Niu Q, Huang D, Wang J, et al.. A SYBR green I–based quantitative RT-PCR assay for bovine ephemeral fever virus and its utility for evaluating viral kinetics in cattle. Journal of Veterinary Diagnostic Investigation. 2019. DOI: https://doi.org/10.1177/1040638719895460

[5] Anis E, Hawkins I, Ilha M, Woldemeskel M, Saliki J, Wilkes R. Evaluation of Targeted Next-Generation Sequencing for Detection of Bovine Pathogens in Clinical Samples. Journal of Clinical Microbiology. 2018. DOI: https://doi.org/10.1128/JCM.00399-18

[6] Reuter G, Boros Á, Pankovics P, Egyed L. Kobuvirus in Domestic Sheep, Hungary. Emerging Infectious Diseases. 2010. DOI: https://doi.org/10.3201/eid1605.091934

[7] Yu J, Jin M, Zhang Q, Li H, Li D, Xu Z, et al.. Candidate Porcine Kobuvirus, China. Emerging Infectious Diseases. 2009. DOI: https://doi.org/10.3201/eid1505.081518

[8] Brito B, Frost M, Webster J, To J, Kirkland PD. Quantifying the impact of sequencing depth and reference genome choice on metatranscriptomic detection of four bovine RNA viruses.. Research in Veterinary Science. 2026. DOI: https://doi.org/10.1016/j.rvsc.2026.106125

[9] Priyantha M, Fernando P, Liyanagunawardana N, Samarakoon N, Dissanayake D, Wijemuni MI, et al.. Status of Bovine Brucellosis in the Submitted Samples at Veterinary Research Institute from 2019 to 2021. Wayamba Journal of Animal Science. 2021. DOI: https://doi.org/10.4038/wjas.v13i0.27

[10] Mamanova S, Bashenova E, Kaimoldina S, Nissanova R, Akshalova P, Kirpichenko V, et al.. OPTIMIZATION OF THE MANUFACTURING CONDITIONS OF AN AGID TEST SYSTEM FOR THE DIAGNOSIS OF BOVINE LEUKEMIA. Eurasian journal of applied biotechnology. 2025. DOI: https://doi.org/10.11134/btp.3.2025.11

[11] Shome R, Natesan K, Kalleshamurthy T, Yadav C, Sahay S, Skariah S, et al.. Management of bovine brucellosis in organized dairy herds through the identification of risk factors: A cross-sectional study from Karnataka, India. Veterinary World. 2023. DOI: https://doi.org/10.14202/vetworld.2023.1122-1130

[12] Bashenova E, Kirpichenko V, Nissanova R, Mamanova S, Dyusenov SM, Lesov B, et al.. DIAGNOSIS OF BOVINE VIRAL DIARRHEA: THE IMPORTANCE OF STANDARDIZING CONTROL SERA FOR INTERLABORATORY COMPARISONS. Ġylym ža̋ne bìlìm. 2025. DOI: https://doi.org/10.52578/2305-9397-2025-3-1-237-248

[13] Tong C, Liu Q, Zhang Z, Liang Y, Feng W, Yu H, et al.. Identification of a target polypeptide of the CD169 receptor of bovine macrophage using a phage display peptide library.. Developmental and Comparative Immunology. 2025. DOI: https://doi.org/10.1016/j.dci.2025.105359

[14] Graham D, More S, O'Sullivan P, Lane E, Barrett D, Lozano J, et al.. The Irish Programme to Eradicate Bovine Viral Diarrhoea Virus, Organization, Challenges, and Progress. Frontiers in Veterinary Science. 2021. DOI: https://doi.org/10.3389/fvets.2021.674557

[15] Chikh M, Ngwa-Mbot D, Morignat E, Mémeteau S, Amat J. OASIS evaluation of the French laboratory diagnostic surveillance system: right people, right techniques but imperfect use. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2025.1419034

[16] Alhussen MA, Fedorova O, Krotova A, Byadovskaya O, Sprygin AV. Validation and application of qPCR test kit for detection of Mycoplasma dispar DNA. Veterinary Science Today. 2025. DOI: https://doi.org/10.29326/2304-196x-2025-14-3-274-282

[17] Burkom H, Estberg L, Akkina J, Meidenbauer KL, Hennessey M. Selection of Syndromes and Algorithms for Monitoring Bovine Laboratory Test Data. Online Journal of Public Health Informatics. 2018. DOI: https://doi.org/10.5210/ojphi.v10i1.8340

[18] Kovalenko V, Borovkov S, Romanko M, Ignatieva T, Liniichuk N, Kusturov VB, et al.. Bactericidal activity and sanitary–microbiological effectiveness of the biocidal preparation “Crezonid”. Ukrainian Journal of Veterinary and Agricultural Sciences. 2026. DOI: https://doi.org/10.32718/ujvas9-1.06